An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...